138 related articles for article (PubMed ID: 15356424)
21. Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.
Hornboll B; Macoveanu J; Rowe J; Elliott R; Paulson OB; Siebner HR; Knudsen GM
J Psychopharmacol; 2013 Oct; 27(10):903-14. PubMed ID: 23824248
[TBL] [Abstract][Full Text] [Related]
22. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
Meltzer HY; Maes M
Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
[TBL] [Abstract][Full Text] [Related]
23. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
[TBL] [Abstract][Full Text] [Related]
24. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
[TBL] [Abstract][Full Text] [Related]
26. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.
Riss PJ; Hong YT; Williamson D; Caprioli D; Sitnikov S; Ferrari V; Sawiak SJ; Baron JC; Dalley JW; Fryer TD; Aigbirhio FI
J Cereb Blood Flow Metab; 2011 Dec; 31(12):2334-42. PubMed ID: 21750562
[TBL] [Abstract][Full Text] [Related]
27. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
[TBL] [Abstract][Full Text] [Related]
28. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
[TBL] [Abstract][Full Text] [Related]
29. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
[TBL] [Abstract][Full Text] [Related]
30. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
[TBL] [Abstract][Full Text] [Related]
31. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
[TBL] [Abstract][Full Text] [Related]
33. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
Matusch A; Hurlemann R; Rota Kops E; Winz OH; Elmenhorst D; Herzog H; Zilles K; Bauer A
J Neural Transm (Vienna); 2007; 114(11):1433-42. PubMed ID: 17541696
[TBL] [Abstract][Full Text] [Related]
34. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
Sànchez C
Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
[TBL] [Abstract][Full Text] [Related]
35. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
Hautzel H; Müller HW; Herzog H; Grandt R
Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
[TBL] [Abstract][Full Text] [Related]
36. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
[TBL] [Abstract][Full Text] [Related]
37. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
38. Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain.
Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Bundgaard C; Bang-Andersen B; Sanchez C; Halldin C; Farde L; Finnema SJ
Neuropsychopharmacology; 2019 Sep; 44(10):1706-1713. PubMed ID: 31216565
[TBL] [Abstract][Full Text] [Related]
39. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine.
Hjorth S
Eur J Pharmacol; 1996 May; 303(3):183-6. PubMed ID: 8813565
[TBL] [Abstract][Full Text] [Related]
40. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
